斗志 发表于 2025-3-25 04:56:01

http://reply.papertrans.cn/29/2827/282610/282610_21.png

重叠 发表于 2025-3-25 10:53:51

http://reply.papertrans.cn/29/2827/282610/282610_22.png

shrill 发表于 2025-3-25 12:50:09

http://reply.papertrans.cn/29/2827/282610/282610_23.png

门窗的侧柱 发表于 2025-3-25 18:03:45

http://reply.papertrans.cn/29/2827/282610/282610_24.png

FLING 发表于 2025-3-25 22:58:10

http://reply.papertrans.cn/29/2827/282610/282610_25.png

Microaneurysm 发表于 2025-3-26 02:44:36

http://reply.papertrans.cn/29/2827/282610/282610_26.png

anarchist 发表于 2025-3-26 06:26:38

http://reply.papertrans.cn/29/2827/282610/282610_27.png

认为 发表于 2025-3-26 11:24:00

https://doi.org/10.1007/978-3-658-10223-4 motor behavior, depression, anxiety, drug abuse, epilepsy, and others. Some ligands of ionotropic receptors have already been introduced to clinical practice (e.g., amantadine, memantine, .-cycloserine), whereas mGluRs may be considered as an emerging target for the treatment of several diseases (e

burnish 发表于 2025-3-26 13:21:25

What Drives Elite-Challenging Behaviours?r antagonists that block the NMDA receptor in a competitive or noncompetitive manner induce schizophrenialike symptoms as well when they are given to humans and also to animals (.–.). More support for the GLU hypothesis derived from postmortem studies showing an increase of NMDA receptor density in

majestic 发表于 2025-3-26 18:48:57

http://reply.papertrans.cn/29/2827/282610/282610_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Dopamine and Glutamate in Psychiatric Disorders; Werner J. Schmidt,Maarten E. A. Reith Book 2005 Humana Press 2005 Alzheimer.Parkinson.att